Eli Lilly (LLY) stands out for its diversified pharmaceutical portfolio, robust pipeline, and strategic acquisitions that are ...

Fintel reports that on November 19, 2025, Truist Securities maintained coverage of Eli Lilly and (NYSE:LLY) with a Buy ...

The stock price now exceeds $1,000, which could potentially make the drugmaker a candidate for a stock split, a ...

Rumors are swirling that pharmaceutical company Eli Lilly (LLY) will be the next major company to split its stock. Claim 60% ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...

Bankers and underwriters have plenty to be thankful for. Bond issuance is running hot, this year’s IPO count is up (at least ...

Though healthcare stocks have been much more measured this year, there are bright spots there as well. The medical-device maker Medtronic (MDT) closed at its highest price since May 12, 2022, after ...

Eli Lilly's tirzepatide acts on two hormonal pathways, so it's called a dual GIP/GLP-1 receptor agonist, and it entered the market as Mounjaro for Type 2 diabetes and as Zepbound for weight management ...

Lilly's tirzepatide is sold as Mounjaro for Type 2 diabetes and as Zepbound for weight loss -- but doctors have prescribed ...

Discover why Pfizer stock may be set for a bull run by 2026 with key wins, strong Q3 earnings, and growth drivers.

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

The pharmaceutical sector is witnessing remarkable momentum behind Eli Lilly, with the diabetes and obesity treatment specialist's stock demonstrating sustai ...